Axogen, Inc. (AXGN) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 0.00 USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 304.86M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $0.00 | (m) | (m) | $304.86M | (m) |
| 2026-03-31 | (m) | (m) | (m) | $0.00 | (m) | (m) | $289.49M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $48.39M | (m) | (m) | $221.69M | (m) |
| 2025-09-30 | (m) | (m) | (m) | $48.16M | (m) | (m) | $216.40M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $47.94M | (m) | (m) | $205.45M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $47.72M | (m) | (m) | $196.16M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $47.50M | (m) | (m) | $203.73M | (m) |
| 2024-09-30 | (m) | (m) | (m) | $47.27M | (m) | (m) | $191.99M | (m) |
| 2024-06-30 | (m) | (m) | (m) | $47.05M | (m) | (m) | $188.93M | (m) |
| 2024-03-31 | (m) | (m) | (m) | $46.83M | (m) | (m) | $186.52M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $46.60M | (m) | (m) | $196.83M | (m) |
| 2023-09-30 | (m) | (m) | (m) | $46.38M | (m) | (m) | $194.63M | (m) |
| 2023-06-30 | (m) | (m) | (m) | $46.15M | (m) | (m) | $191.64M | (m) |
| 2023-03-31 | (m) | (m) | (m) | $45.93M | (m) | (m) | $189.47M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $45.71M | (m) | (m) | $195.39M | (m) |
| 2022-09-30 | (m) | (m) | (m) | $45.49M | (m) | (m) | $195.52M | (m) |
| 2022-06-30 | (m) | (m) | (m) | $45.26M | (m) | (m) | $196.08M | (m) |
| 2022-03-31 | (m) | (m) | (m) | $45.04M | (m) | (m) | $198.03M | (m) |
| 2021-12-31 | (m) | (m) | (m) | $44.82M | (m) | (m) | $208.02M | (m) |
| 2021-09-30 | (m) | (m) | (m) | $46.24M | (m) | (m) | $209.97M | (m) |
| 2021-06-30 | (m) | (m) | (m) | $46.08M | (m) | (m) | $210.53M | (m) |
| 2021-03-31 | (m) | (m) | (m) | $32.14M | (m) | (m) | $197.37M | (m) |
| 2020-12-31 | (m) | (m) | (m) | $32.03M | (m) | (m) | $201.38M | (m) |
| 2020-09-30 | (m) | (m) | $2.50M | $18.98M | (m) | (m) | $193.94M | (m) |
| 2020-06-30 | (m) | (m) | $1.55M | (m) | (m) | (m) | $169.96M | (m) |
| 2020-03-31 | (m) | (m) | $1.78M | $1.19M | (m) | (m) | $144.88M | (m) |
| 2019-12-31 | (m) | (m) | $1.74M | $1.59M | (m) | (m) | $154.64M | (m) |
| 2019-09-30 | (m) | (m) | $1.77M | $2.00M | (m) | (m) | $154.19M | (m) |
| 2019-06-30 | (m) | (m) | $1.83M | $2.38M | (m) | (m) | $156.60M | (m) |
| 2019-03-31 | (m) | (m) | $1.36M | $3.22M | (m) | (m) | $160.49M | (m) |
| 2018-12-31 | (m) | (m) | $28.00K | $35.00K | (m) | (m) | $160.17M | (m) |
| 2018-09-30 | (m) | (m) | $35.96K | $38.31K | (m) | (m) | $161.66M | (m) |
| 2018-06-30 | (m) | (m) | $39.03K | $45.24K | (m) | (m) | $160.54M | (m) |
| 2018-03-31 | (m) | (m) | $2.84M | $17.76M | (m) | (m) | $55.17M | (m) |
| 2017-12-31 | (m) | (m) | $735.02K | $19.91M | (m) | (m) | $58.87M | (m) |
| 2017-09-30 | (m) | (m) | $21.60K | $20.36M | (m) | (m) | $42.23M | (m) |
| 2017-06-30 | (m) | (m) | $24.95K | $20.31M | (m) | (m) | $42.77M | (m) |
| 2017-03-31 | (m) | (m) | $22.91K | $20.28M | (m) | (m) | $43.27M | (m) |
| 2016-12-31 | (m) | (m) | $20.90K | $20.27M | (m) | (m) | $46.36M | (m) |
| 2015-12-31 | (m) | (m) | (m) | $25.55M | (m) | (m) | $37.55M | (m) |
| 2014-12-31 | (m) | (m) | (m) | $25.09M | (m) | (m) | $16.40M | (m) |
| 2014-09-30 | (m) | (m) | (m) | $28.17M | (m) | (m) | $20.10M | (m) |
| 2014-06-30 | (m) | (m) | (m) | $27.24M | (m) | (m) | $22.40M | (m) |
| 2014-03-31 | (m) | (m) | (m) | $26.26M | (m) | (m) | $24.57M | (m) |
| 2013-12-31 | (m) | (m) | (m) | $25.36M | (m) | (m) | $27.68M | (m) |
| 2013-09-30 | (m) | (m) | (m) | $24.33M | (m) | (m) | $29.76M | (m) |
| 2013-06-30 | (m) | (m) | (m) | $23.38M | (m) | (m) | $15.67M | (m) |
| 2013-03-31 | (m) | (m) | (m) | $22.44M | (m) | (m) | $17.85M | (m) |
| 2012-12-31 | (m) | (m) | (m) | $21.58M | (m) | (m) | $20.23M | (m) |
| 2012-09-30 | (m) | (m) | $1.89M | $4.74M | (m) | (m) | $9.69M | (m) |
| 2012-06-30 | (m) | (m) | $1.40M | $3.46M | (m) | (m) | $9.84M | (m) |
| 2012-03-31 | (m) | (m) | $918.48K | $3.93M | (m) | (m) | $10.48M | (m) |
| 2011-12-31 | (m) | (m) | $434.73K | $4.40M | (m) | (m) | $12.50M | (m) |
| 2011-09-30 | (m) | (m) | $0.00 | $4.83M | (m) | (m) | $14.44M | (m) |
| 2010-12-31 | (m) | (m) | $7.08M | $0.00 | (m) | (m) | $6.41M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |